Pfizer Seeks Paxlovid Approval, Which Could Open Sales To Private Market

By Gabrielle Wanneh / June 30, 2022 at 6:40 PM
Pfizer applied Thursday (June 30) for FDA approval of its oral coronavirus antiviral Paxlovid for use in patients at high-risk of severe illness, regardless of vaccination status -- a request that if granted would let Pfizer start advertising the drug and sell it on the private market. Paxlovid is currently authorized for emergency use so only the federal government can buy it. A full approval would allow Pfizer to sell Paxlovid in the private market, which would free the company...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.